Literature DB >> 31541729

Introduction of fluorine atoms to vitamin D3 side-chain and synthesis of 24,24-difluoro-25-hydroxyvitamin D3.

Fumihiro Kawagoe1, Sayuri Mototani2, Kaori Yasuda3, Kazuo Nagasawa4, Motonari Uesugi5, Toshiyuki Sakaki3, Atsushi Kittaka6.   

Abstract

During our ongoing studies of vitamin D, we focused on the vitamin D3 side-chain 24-position, which is the major metabolic site of human CYP24A1. In order to inhibit the metabolism of vitamin D3, 24,24-difluorovitamin D3analogues are important candidates. In this paper, we report the practical introduction of the difluoro-unit to the 24-position to synthesize 24,24-difluoro-CD ring (1) and 24,24-difluoro-25-hydroxyvitamin D3 (2).
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  24,24-Difluoro-CD rings; 24,24-Difluorovitamin D(3) analogues; CYP24A1; Synthesis; Vitamin D(3) metabolite

Year:  2019        PMID: 31541729     DOI: 10.1016/j.jsbmb.2019.105477

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  3 in total

1.  Stereoselective Synthesis of 24-Fluoro-25-Hydroxyvitamin D3 Analogues and Their Stability to hCYP24A1-Dependent Catabolism.

Authors:  Fumihiro Kawagoe; Sayuri Mototani; Kaori Yasuda; Hiroki Mano; Toshiyuki Sakaki; Atsushi Kittaka
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

Review 2.  Development of In Vitro and In Vivo Evaluation Systems for Vitamin D Derivatives and Their Application to Drug Discovery.

Authors:  Kaori Yasuda; Miyu Nishikawa; Hiroki Mano; Masashi Takano; Atsushi Kittaka; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

3.  The First Convergent Synthesis of 23,23-Difluoro-25-hydroxyvitamin D3 and Its 24-Hydroxy Derivatives: Preliminary Assessment of Biological Activities.

Authors:  Sayuri Mototani; Fumihiro Kawagoe; Kaori Yasuda; Hiroki Mano; Toshiyuki Sakaki; Atsushi Kittaka
Journal:  Molecules       Date:  2022-08-22       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.